CHRNA7 and Crush Syndrome: Our previous studies also demonstrated the effects of anisodamine on crush syndrome-related shock by increasing blood pressure in crush syndrome rats, which relied on the activation of α7 nicotinic acetylcholine receptor (α7nAChR) (Yu et al., 2019; Fan et al., 2016) (Figure 1: Anti-shock drugs).